Exit
Sapin II: A new era of anti-corruption law in France

Sapin II: A new era of anti-corruption law in France

The anti-corruption law known as “Sapin II” was passed on 11 December 2016 in the hopes of bringing French anti-corruption legislation in line with the strictest European and international standards. Global companies need to take notice because the new law is essentially the first of its kind in France.  Prior to Sapin II, the laws […]

Read more
Retour d'expérience de la 1ère publication EFPIA

Feedback From the 1st EFPIA Disclosure

During the last event jointly organized by BMI SYSTEM and LCH Avocats, Laurent Clerc, from BMI SYSTEM, presented an analysis of the 1st EFPIA disclosure for five countries. Focus on Five Countries Several EFPIA member countries for which disclosure information was readily available were discussed throughout the morning. It is important to note that the […]

Read more
Event Zurich

5th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry

Read more

BMI SYSTEM Newsletter – January 2017

The BMI SYSTEM Newsletter of January 2017 has just been published. Click below to take a look: To subscribe:

Read more
Actualités sur la transparence en France

Transparency News in France

The event organized by BMI SYSTEM and LCH law firm on the 17th of November 2016 provided the opportunity to address the different regulatory evolutions in DMOS (Anti- Bribery) and Transparency. The decree promulgated on the 28th December 2016, will have an impact on the organization and management tools of the companies impacted. Remunerations will […]

Read more
Event London

The London Global Compliance Congress for Life Science: BMI SYSTEM was there!

Last November, BMI SYSTEM attended with our partner Meetings & Events International (MEI), one of the biggest events on compliance in our industry: London Global Compliance Congress for Life Science. It was the opportunity for people in the industry to discuss and share their experience and key learnings after the first EFPIA Public Disclosures and […]

Read more
Close
Go top